165 related articles for article (PubMed ID: 21928364)
1. Clinical significance of KISS1 protein expression for brain invasion and metastasis.
Ulasov IV; Kaverina NV; Pytel P; Thaci B; Liu F; Hurst DR; Welch DR; Sattar HA; Olopade OI; Baryshnikov AY; Kadagidze ZG; Lesniak MS
Cancer; 2012 Apr; 118(8):2096-105. PubMed ID: 21928364
[TBL] [Abstract][Full Text] [Related]
2. Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy.
Kaverina N; Borovjagin AV; Kadagidze Z; Baryshnikov A; Baryshnikova M; Malin D; Ghosh D; Shah N; Welch DR; Gabikian P; Karseladze A; Cobbs C; Ulasov IV
Autophagy; 2017; 13(11):1905-1923. PubMed ID: 28981380
[TBL] [Abstract][Full Text] [Related]
3. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.
Stark AM; Tongers K; Maass N; Mehdorn HM; Held-Feindt J
J Cancer Res Clin Oncol; 2005 Mar; 131(3):191-8. PubMed ID: 15592684
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 345 (miR345) regulates KISS1-E-cadherin functional interaction in breast cancer brain metastases.
Ulasov I; Borovjagin A; Fares J; Yakushov S; Malin D; Timashev P; Lesniak MS
Cancer Lett; 2020 Jul; 481():24-31. PubMed ID: 32246957
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of KiSS1 as a Prognostic Biomarker in North Indian Breast Cancer Cases.
Singh R; Bhatt ML; Singh SP; Kumar V; Goel MM; Mishra DP; Kumar R
Asian Pac J Cancer Prev; 2016; 17(4):1789-95. PubMed ID: 27221854
[TBL] [Abstract][Full Text] [Related]
6. KISS1 tumor suppressor restricts angiogenesis of breast cancer brain metastases and sensitizes them to oncolytic virotherapy in vitro.
Platonov ME; Borovjagin AV; Kaverina N; Xiao T; Kadagidze Z; Lesniak M; Baryshnikova M; Ulasov IV
Cancer Lett; 2018 Mar; 417():75-88. PubMed ID: 29269086
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of KiSS1 and KiSS1R expression in human primary breast cancer: Association with breast cancer receptor status, proliferation markers and clinicopathological features.
Jarzabek K; Koda M; Kozlowski L; Milewski R; Wolczynski S
Histol Histopathol; 2015 Jun; 30(6):715-23. PubMed ID: 25535062
[TBL] [Abstract][Full Text] [Related]
8. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
[TBL] [Abstract][Full Text] [Related]
9. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
[TBL] [Abstract][Full Text] [Related]
10. A twisted kiss: in vitro and in vivo evidence of genetic variation and suppressed transcription of the metastasis-suppressor gene KiSS1 in early breast cancer.
Pentheroudakis G; Kostadima L; Dova L; Georgiou I; Tzavaras T; Vartholomatos G; Wirtz RM; Fountzilas G; Malamou-Mitsi V; Pavlidis N
Neoplasma; 2010; 57(1):47-54. PubMed ID: 19895172
[TBL] [Abstract][Full Text] [Related]
11. Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.
Duchnowska R; Jassem J; Goswami CP; Dundar M; Gökmen-Polar Y; Li L; Woditschka S; Biernat W; Sosińska-Mielcarek K; Czartoryska-Arłukowicz B; Radecka B; Tomasevic Z; Stępniak P; Wojdan K; Sledge GW; Steeg PS; Badve S
J Neurooncol; 2015 Mar; 122(1):205-16. PubMed ID: 25559688
[TBL] [Abstract][Full Text] [Related]
12. KISS1 in breast cancer progression and autophagy.
Ulasov IV; Borovjagin AV; Timashev P; Cristofanili M; Welch DR
Cancer Metastasis Rev; 2019 Sep; 38(3):493-506. PubMed ID: 31705228
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
14. Inverse Correlation of KISS1 and KISS1R Expression in Triple-negative Breast Carcinomas from African American Women.
Qasim M; Ricks-Santi LJ; Naab TJ; Rajack F; Beyene D; Abbas M; Kassim OO; Copeland RL; Kanaan Y
Cancer Genomics Proteomics; 2022; 19(6):673-682. PubMed ID: 36316037
[TBL] [Abstract][Full Text] [Related]
15. Different therapeutic effects of distinct KISS1 fragments on breast cancer in vitro and in vivo.
Song GQ; Zhao Y
Int J Oncol; 2013 Oct; 43(4):1219-27. PubMed ID: 23900657
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphisms in metastasis suppressor genes NME1 and KISS1 with breast cancer development and metastasis.
Antar S; Mokhtar N; Abd Elghaffar MA; Seleem AK
J Egypt Natl Canc Inst; 2020 May; 32(1):24. PubMed ID: 32462300
[TBL] [Abstract][Full Text] [Related]
17. Expressional alterations and transcript isoforms of metastasis suppressor genes (KAI1 and KiSS1) in breast cancer patients.
Mooez S; Malik FA; Kayani MA; Rashid R; Zahid A; Khan A
Asian Pac J Cancer Prev; 2011; 12(10):2785-91. PubMed ID: 22320993
[TBL] [Abstract][Full Text] [Related]
18. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
19. Reduced Kiss‑1 expression is associated with clinical aggressive feature of gastric cancer patients and promotes migration and invasion in gastric cancer cells.
Li C; Yuan L; Han S; Xuan M; Liu D; Tian B; Yu W
Oncol Rep; 2020 Sep; 44(3):1149-1157. PubMed ID: 32705229
[TBL] [Abstract][Full Text] [Related]
20. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
